AI assistant
Sending…
GENTEX CORP — Director's Dealing 2023
Feb 2, 2023
30893_dirs_2023-02-02_94cde1a2-0d42-450c-9ea3-d0f7923bf808.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2023-02-01
Reporting Person: Nash Kevin C (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-02-01 | Common Stock | M | 6776.00 | $14.70 | Acquired | 28508.00 | Direct |
| 2023-02-01 | Common Stock | S | 6776.00 | $29.4233 | Disposed | 22597.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-02-01 | Employee Stock Option (Right to buy) | $14.70 | M | 6776.00 | Disposed | 2023-02-22 | Common Stock (6776.00) | Direct |
Footnotes
F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
F2: This transaction was executed in multiple trades at prices ranging from $29.32 to $29.56. The price reported above reflects the weighted average price.
F3: Column 5 reflects the acquisition of 865 shares under the Gentex Corp. Employee Stock Purchase Plan.
F4: These shares become exercisable as to 20% one year after date of grant and an additional 20% at each ensuing anniversary date.
More from GENTEX CORP
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Feb 24
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19